+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vertex Pharmaceuticals Inc.  - logo

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines. Founded in 1989 in Cambridge, MA, Vertex has research and development sites and commercial offices around the world in the United States, Canada, Europe and Australia. In May 2011, the U.S. Food and Drug Administration (FDA) approved Vertex’s first medicine, a treatment for hepatitis C. In 2012, Vertex received approval for our medicine for cystic fibrosis in the U.S., Europe and Canada. Vertex received Australian approval of our medicine for cystic fibrosis in 2013.

From
From
From
From
From
Dystrophin (DMD) - Drugs In Development, 2021 - Product Thumbnail Image

Dystrophin (DMD) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 161 Pages
From
From
From
From
Global Hepatitis C Drugs Market 2021-2025 - Product Thumbnail Image

Global Hepatitis C Drugs Market 2021-2025

  • Report
  • January 2021
  • 120 Pages
From
Loading Indicator